Organization
University of Iowa Hospitals & Clinics
13 abstracts
Abstract
Comparison of concurrent care and traditional hospice at a regional VA.Org: University of Iowa Hospitals & Clinics, Iowa City VA Medical Center,
Abstract
Responses to immune checkpoint inhibitor therapy in NF1 mutated cutaneous melanoma.Org: Holden Comprehensive Cancer Center, University of Iowa Hospitals & Clinics, University of Iowa Hospitals and Clinics,
Abstract
AMPLIFY-201, a first-in-human safety and efficacy trial of adjuvant ELI-002 2P immunotherapy for patients with high-relapse risk with KRAS G12D- or G12R-mutated pancreatic and colorectal cancer.Org: Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College University, University of California at Los Angeles, Massachusetts General Hospital, University of Iowa Hospitals & Clinics,
Abstract
Genetic heterogeneity between paired primary and metastatic solid tumors and implications for neoantigen-based personalized cancer vaccines.Org: H. Lee Moffitt Cancer Center and Research Institute, M2GEN, Huntsman Cancer Institute at the University of Utah, Stephenson Cancer Center, Ohio State University Wexner Medical Center,
Abstract
Immune infiltrates in metastatic uveal melanoma liver metastases and associations with clinical outcomes.Org: Mayo Clinic, Holden Comprehensive Cancer Center, University of Iowa Hospitals & Clinics,
Abstract
Wireless transcutaneous electric nerve stimulation (TENS) for chemotherapy-induced peripheral neuropathy (CIPN): A proof-of-concept, placebo-controlled, randomized clinical trial (RCT).Org: University of Rochester Medical Center Department of Neurobiology and Anatomy, University of Rochester Medical Center, Wilmot Cancer Institute, Cancer Research of Wisconsin and Northern Michigan (CROWN) NCORP, Upstate Carolina NCORP,
Abstract
Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): Extended follow up and biweekly administration from the MagnetisMM-3 study.Org: Sorbonne University and Saint-Antoine Hospital, Hôpital Saint-Antoine, INSERM UMRs938, Holden Comprehensive Cancer Center, University of Iowa Hospitals & Clinics,
Abstract
Immuno-embolization plus PD1 antibody in metastatic uveal melanoma.Org: Holden Comprehensive Cancer Center, University of Iowa Hospitals & Clinics, University of Missouri-Kansas City School of Medicine, Division of Vascular and Interventional Radiology,
Abstract
Real-world assessment of treatment effectiveness in patients with advanced non-small cell lung cancer (aNSCLC) with MET exon 14 skipping (METex14).Org: University of Iowa Hospitals & Clinics, Carver College of Medicine - University of Iowa, Iowa City, IA, RTI Health Solutions, Research Triangle Park, NC,
Abstract
Updated analysis of real-world treatment outcomes of first-line axitinib plus pembrolizumab in patients with advanced renal cell carcinoma in the United States.Org: University of Iowa Hospitals & Clinics, Iowa City VA Medical Center, Pfizer, New York Oncology Hematology PC, Nykode Therapeutics,
Abstract
Therapy preferences of patients with cancer.Org: University of Iowa Hospitals & Clinics, Iowa City VA Medical Center, Iambic Therapeutics, University of Nebraska Medical Center, Omaha NE,
Abstract
2019 LUPUS CLASSIFICATION CRITERIA SCORE PREDICTS FUTURE LUPUS HOSPITAL ADMISSIONOrg: University of Kentucky, Lexington, KY, Cairo University, University of Iowa Hospitals & Clinics,
Abstract
ASSOCIATION OF RHEUMATOID ARTHRITIS WITH MORTALITY IN A COHORT OF CHRONIC KIDNEY DISEASE PATIENTSOrg: Skagit Regional Health, University of Washington and Fred Hutchinson Cancer Research Centre, University of Connecticut Internal Medicine Residency Program, UPMC Presbyterian Shadyside, Howard University Hospital,